Lanean...
Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms
High grade neuroendocrine neoplasms (G3 NENs) are rare aggressive tumors with limited treatment options. Twenty-one previously treated patients with metastatic extra-pulmonary G3 NENs were treated with pembrolizumab. Baseline tumor samples were assessed for PD-L1 and tumor infiltrating lymphocytes (...
Gorde:
| Argitaratua izan da: | Cancer Immunol Immunother |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer Berlin Heidelberg
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8195815/ https://ncbi.nlm.nih.gov/pubmed/33398390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-020-02811-5 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|